Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors

Rossi, Amerigo; Frechette, Laena; Miller, Devin; Miller, Eirwen M.; Friel, Ciarán P.; Arsdale, Anne Van; Lin, Juan; Shankar, Viswanathan; Kuo, D.Y.S.; Nevadunsky, Nicole S.

doi:10.1016/j.ygyno.2018.04.560

Cited by 46 publications

(35 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A recent review and meta‐analysis of such interventions indicated that, of 29 randomized controlled trials published within the past 5 years, only 10 reported follow‐up information . Wearable‐based interventions for cancer survivors have emerged recently; however, most are feasibility and/or pilot studies using single‐group designs (for example, see Gell et al, Le et al, and Rossi et al), and no follow‐up data have been published to date. Results of the ACTIVATE Trial suggest that wearable technology can facilitate a more active lifestyle for cancer survivors beyond the active intervention phase.…”

Section: Discussionmentioning

confidence: 99%

Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention: Secondary outcomes from the ACTIVATE Trial

Lynch

Nguyen

Moore

et al. 2019

Cancer

View full text Add to dashboard Cite

Background This brief report examines the maintenance of moderate to vigorous physical activity (MVPA) and sedentary behavior changes approximately 12 weeks after the delivery of the ACTIVATE Trial primary intervention (use of the Garmin Vivofit 2 activity tracker coupled with a behavioral feedback and goal‐setting session and 5 telephone‐delivered health coaching sessions). We also examine the efficacy of an abridged intervention (use of the Garmin Vivofit 2 only) in the waitlist control group. Methods A pre‐post design was employed to examine the secondary aims of the ACTIVATE Trial (n = 80; mean age = 62 years). MVPA and sedentary behavior were measured using Actigraph and activPAL accelerometers after delivery of the primary intervention (T2), and again 12 weeks later (T3). Linear mixed models with random effects were used to examine within‐group changes in MVPA and sitting time variables. Results After the 12‐week follow‐up period, women in the primary intervention group had maintained their higher levels of MVPA (change from T2 to T3 = 14 min/wk; 95% CI = −18 to 46; P = .37). However, their sitting time increased slightly, by 7 min/d (95% CI = −20 to 34; P = .58), but it did not return to its preintervention level. After receiving the Garmin Vivofit 2, the waitlist control group increased their MVPA by 33 min/wk (95% CI = 3‐64; P = .03) and reduced their sitting time by 38 min/d (95% CI = −69 to −7; P = .02) over the same 12‐week period. Conclusion The secondary outcomes from the ACTIVATE Trial suggest that wearable technology may generate sustainable changes in MVPA and sitting time. Wearable technology alone may be sufficient to change behavior, at least in the short term.

show abstract

Section: Discussionmentioning

confidence: 99%

Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention: Secondary outcomes from the ACTIVATE Trial

Lynch

Nguyen

Moore

et al. 2019

Cancer

View full text Add to dashboard Cite

show abstract

“…Research generally supports the validity of commercial wearable devices for activity measurement 15 , although there is some evidence that step counts may be less accurate with slower gait speed or assistive device use 16 . Collection of activity data using consumer devices has been demonstrated to be feasible and acceptable among cancer patients in active treatment 17 – 20 . The wearable device literature builds on early studies with older-generation research-grade accelerometers 21 , which have been shown to correlate with consumer activity tracker data in cancer patients 22 .…”

Section: Consumer Wearable Devices In Oncology Researchmentioning

confidence: 99%

Harnessing consumer smartphone and wearable sensors for clinical cancer research

Low

2020

npj Digit. Med.

View full text Add to dashboard Cite

As smartphones and consumer wearable devices become more ubiquitous, there is a growing opportunity to capture rich mobile sensor data continuously, passively, and in real-world settings with minimal burden. In the context of cancer, changes in these passively sensed digital biomarkers may reflect meaningful variation in functional status, symptom burden, quality of life, and risk for adverse clinical outcomes. These data could enable real-time remote monitoring of patients between clinical encounters and more proactive, comprehensive, and personalized care. Over the past few years, small studies across a variety of cancer populations support the feasibility and potential clinical value of mobile sensors in oncology. Barriers to implementing mobile sensing in clinical oncology care include the challenges of managing and making sense of continuous sensor data, patient engagement issues, difficulty integrating sensor data into existing electronic health systems and clinical workflows, and ethical and privacy concerns. Multidisciplinary collaboration is needed to develop mobile sensing frameworks that overcome these barriers and that can be implemented at large-scale for remote monitoring of deteriorating health during or after cancer treatment or for promotion and tailoring of lifestyle or symptom management interventions. Leveraging digital technology has the potential to enrich scientific understanding of how cancer and its treatment affect patient lives, to use this understanding to offer more timely and personalized support to patients, and to improve clinical oncology outcomes.

show abstract

“…Similarly to previous research, the use of an activity tracker was well-accepted by the study participants. 22,23,32 Overall, participants reported that the activity tracker was easy to use and was helpful in assisting them to increase or maintain their activity levels. This is supported by the results of the RCT, which demonstrate an initial increase in daily step count between baseline and three-months and maintenance of daily steps between baseline and 12-months (data not yet published).…”

Section: Acceptabilitymentioning

confidence: 99%

“…One of the common themes identified in the current literature [22][23][24] is an increase in self-awareness resulting in increased motivation to improve or maintain physical activity behaviours. While this theme was also identified in the current study, we found that the increased awareness did not necessarily translate to increased motivation.…”

Section: Thematic Analysismentioning

confidence: 99%

Older adults’ experiences of using a wearable activity tracker with health professional feedback over a 12-month randomised controlled trial

et al. 2020

View full text Add to dashboard Cite

Objective Wearable activity trackers can help older adults remain physically active. However, knowledge of the user experience during long-term use is scarce. Therefore, this study examined older adults’ experiences with, and perceptions of, wearable activity trackers combined with health professional feedback after a year’s use as part of a randomised controlled trial. Methods Twenty older adults (73.6 ± 5.5 years) who had used a Jawbone UP24 activity tracker for 12 months during a randomised controlled trial were recruited for this study. All participants had at least one chronic condition. Acceptability data relating to activity tracker wear time was combined with focus group data to explore participants experiences of long-term activity tracker use. Data was analysed using thematic analysis. Results The activity tracker was well-accepted with the device worn on an average of 86% of possible days and participants reported an overall positive experience. Four themes were identified: (a) increased sense of awareness of activity levels is related to motivation; (b) the level of engagement with the activity tracker influences the user experience; (c) the role of feedback from a health professional in providing ongoing support; d) the role of habits in supporting long-term behaviour change. Conclusions The use of an activity tracker combined with health professional support can assist older adults to maintain their activity levels over 12 months. Consideration should be given to the previous technology experience of users and the design and accuracy of an activity tracker when recommending their use in a research or clinical setting.

show abstract

Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors

Cited by 46 publications

References 24 publications

Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention: Secondary outcomes from the ACTIVATE Trial

Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention: Secondary outcomes from the ACTIVATE Trial

Harnessing consumer smartphone and wearable sensors for clinical cancer research

Older adults’ experiences of using a wearable activity tracker with health professional feedback over a 12-month randomised controlled trial

Contact Info

Product

Resources

About